Coeptis Announces Merger with Z Squared, Transitions to Digital Asset Mining Company

According to The Block, Coeptis Therapeutics will merge with Z Squared, a company focused on Dogecoin mining, and plans to rename itself as Z Squared, officially transitioning from a biopharmaceutical company to a digital asset mining enterprise. The merger will include the acquisition of 9,000 Dogecoin mining machines and the divestment of its existing biopharmaceutical division.

As a result of this announcement, Coeptis' stock price plummeted nearly 40%, with a current market value of approximately $32 million. The new company will be led by Z Squared's current CEO David Halabu and COO Michelle Burke, aiming to become the largest publicly traded Dogecoin mining company in the United States.